For the Inventor, By the Inventor

Enter assignee name

Newark, CA, United States of America

Depomed, Inc.

USPTO Granted Patents = 51

CIPO Patents = 7

EPO Patents = 5

Trademarks = 11

Forward Citations = 2,115

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Bret Berner (29 out of 65 patents)

Sui Yuen Eddie Hou (24 out of 27 patents)

Gloria Gusler (17 out of 18 patents)

4. Jenny Louie-Helm (14 out of 14 patents)

5. John N Shell (9 out of 9 patents)

6. John W Shell (7 out of 25 patents)

7. Jong Lim (4 out of 4 patents)

8. Chien-Hsuan Han (4 out of 7 patents)

9. Monica L Reid (4 out of 4 patents)

10. Peter James Watts (3 out of 23 patents)

11. Jonathan David Castile (3 out of 9 patents)

12. Alan Smith (3 out of 21 patents)

13. Cuiping Chen (3 out of 5 patents)

14. Micheline Markey (3 out of 3 patents)

15. William Columbus Ian Lafferty (2 out of 3 patents)

Core Competencies:

Gastric Retentive Dosage Forms

Pharmaceutical Compositions

Intranasal Spray Device

Dual Drug Dosage Forms

Zero-Order Drug Release

Gabapentin Dosage Form

Non-Opioid Analgesics

Opioid Analgesics

Extended Release Formulations

CNS Disorders Treatment

Pain Management Techniques

GABA Analogs

51 patents: Sort by Forward Citations

1. 9980903 - Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract (2018-05-29),

2. 9937142 - Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders (2018-04-10),

3. 9814705 - Intranasal spray device containing pharmaceutical composition (2017-11-14),

4. 9801816 - Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract (2017-10-31),

5. 9597338 - Shell-and-core dosage form approaching zero-order drug release (2017-03-21),

6. 9572780 - Dual drug dosage forms with improved separation of drugs (2017-02-21),

7. 9566258 - Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders (2017-02-14),

8. 9561200 - Method of treating post-surgical acute pain (2017-02-07),

9. 9301934 - Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract (2016-04-05),

10. 9161911 - Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders (2015-10-20),

11. 9078814 - Intranasal spray device containing pharmaceutical composition (2015-07-14),

12. 9000046 - Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract (2015-04-07),

13. 8999388 - Dual drug dosage forms with improved separation of drugs (2015-04-07),

14. 8945619 - Shell-and-core dosage form approaching zero-order drug release (2015-02-03),

15. 8889176 - Method of managing or treating pain (2014-11-18),

Depomed, Inc. is a pharmaceutical company that develops and commercializes specialty medicines for the treatment of pain, central nervous system disorders, and other related conditions. With a focus on developing proprietary formulations, Depomed aims to provide innovative solutions to improve patients' lives. Through its scientific expertise and strategic partnerships, the company takes a patient-centric approach to deliver high-quality medications. For more information, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

51 Patents

#10 in Newark, CA

#1,580 in California

#6,663 in US

#13,381 in the World

Newark, CA, United States of America

Depomed, Inc.

Forward Citations = 2,115

27 inventors:

Bret Berner (29 out of 65 patents)

Sui Yuen Eddie Hou (24 out of 27 patents)

Gloria Gusler (17 out of 18 patents)

4. Jenny Louie-Helm (14 out of 14 patents)

5. John N Shell (9 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…